BOSTON CAPITAL TAX CREDIT FUND III L P

CIK:0000879555|SEC Filings

CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		6 Months Ended
CONDENSED STATEMENTS OF OPERATIONS - USD ($)	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Income
Interest income	$ 3,290	$ 2,891	$ 6,548	$ 6,597
Other income	6,000	100,693	7,133	110,969
Total income	9,290	103,584	13,681	117,566
Gain on Disposition of Operating Partnerships	47,500		47,500	841,020
Expenses
Professional fees	57,719	14,080	57,719	103,137
Fund management fee, net (Note C)	33,315	55,128	71,434	108,538
General and administrative expenses	25,732	36,624	47,078	58,684
Operating expenses	116,766	105,832	176,231	270,359
NET INCOME (LOSS)	(59,976)	(2,248)	(115,050)	688,227
Net income (loss) allocated to limited assignees	(59,376)	(2,225)	(113,899)	681,345
Net income (loss) allocated to general partner	$ (600)	(23)	$ (1,151)	$ 6,882
Net income (loss) per BAC	$ 0.00		$ (0.01)	$ 0.03
Series 15
Income
Interest income	$ 0	367	$ 0	$ 800
Other income	0	0	0	0
Total income	0	367	0	800
Gain on Disposition of Operating Partnerships	0	0	0	12,500
Expenses
Professional fees	0	2,960	0	21,240
Fund management fee, net (Note C)	0	8,772	0	15,912
General and administrative expenses	0	7,137	0	11,384
Operating expenses	0	18,869	0	48,536
NET INCOME (LOSS)	0	(18,502)	0	(35,236)
Net income (loss) allocated to limited assignees	0	(18,317)	0	(34,884)
Net income (loss) allocated to general partner	$ 0	$ (185)	$ 0	$ (352)
Net income (loss) per BAC	$ 0.00	$ 0.00	$ 0.00	$ (0.01)
Series 16
Income
Interest income	$ 474	$ 415	$ 930	$ 864
Other income	0	1,677	200	1,878
Total income	474	2,092	1,130	2,742
Gain on Disposition of Operating Partnerships	47,500	0	47,500	0
Expenses
Professional fees	21,287	3,200	21,287	24,625
Fund management fee, net (Note C)	15,523	16,271	30,350	30,756
General and administrative expenses	10,032	8,160	18,260	13,358
Operating expenses	46,842	27,631	69,897	68,739
NET INCOME (LOSS)	1,132	(25,539)	(21,267)	(65,997)
Net income (loss) allocated to limited assignees	1,121	(25,284)	(21,054)	(65,337)
Net income (loss) allocated to general partner	$ 11	$ (255)	$ (213)	$ (660)
Net income (loss) per BAC	$ 0.00	$ 0.00	$ 0.00	$ (0.01)
Series 17
Income
Interest income	$ 2,102	$ 1,294	$ 4,296	$ 2,132
Other income	0	98,000	0	108,075
Total income	2,102	99,294	4,296	110,207
Gain on Disposition of Operating Partnerships	0	0	0	0
Expenses
Professional fees	16,089	2,480	16,089	22,812
Fund management fee, net (Note C)	8,844	12,219	16,688	21,438
General and administrative expenses	9,076	7,541	16,485	12,127
Operating expenses	34,009	22,240	49,262	56,377
NET INCOME (LOSS)	(31,907)	77,054	(44,966)	53,830
Net income (loss) allocated to limited assignees	(31,588)	76,284	(44,516)	53,292
Net income (loss) allocated to general partner	$ (319)	$ 770	$ (450)	$ 538
Net income (loss) per BAC	$ (0.01)	$ 0.02	$ (0.01)	$ 0.01
Series 18
Income
Interest income	$ 714	$ 496	$ 1,322	$ 2,168
Other income	6,000	933	6,933	933
Total income	6,714	1,429	8,255	3,101
Gain on Disposition of Operating Partnerships	0	0	0	815,520
Expenses
Professional fees	20,343	2,900	20,343	18,675
Fund management fee, net (Note C)	8,948	15,448	24,396	33,499
General and administrative expenses	6,624	6,841	12,333	10,839
Operating expenses	35,915	25,189	57,072	63,013
NET INCOME (LOSS)	(29,201)	(23,760)	(48,817)	755,608
Net income (loss) allocated to limited assignees	(28,909)	(23,522)	(48,329)	748,052
Net income (loss) allocated to general partner	$ (292)	$ (238)	$ (488)	$ 7,556
Net income (loss) per BAC	$ (0.01)	$ (0.01)	$ (0.01)	$ 0.21
Series 19
Income
Interest income	$ 0	$ 319	$ 0	$ 633
Other income	0	83	0	83
Total income	0	402	0	716
Gain on Disposition of Operating Partnerships	0	0	0	13,000
Expenses
Professional fees	0	2,540	0	15,785
Fund management fee, net (Note C)	0	2,418	0	6,933
General and administrative expenses	0	6,945	0	10,976
Operating expenses	0	11,903	0	33,694
NET INCOME (LOSS)	0	(11,501)	0	(19,978)
Net income (loss) allocated to limited assignees	0	(11,386)	0	(19,778)
Net income (loss) allocated to general partner	$ 0	$ (115)	$ 0	$ (200)
Net income (loss) per BAC	$ 0.00	$ 0.00	$ 0.00	$ 0.00

CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	Sep. 30, 2019	Sep. 30, 2018
Cash flows from operating activities:
Net Income (Loss)	$ (115,050)	$ 688,227
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on Disposition of Operating Partnerships	(47,500)	(841,020)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	2,000	(2,000)
(Decrease) Increase in accounts payable affiliates	(1,144)	(1,040,288)
Net cash provided by (used in) operating activities	(161,694)	(1,195,081)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	47,500	841,020
Net cash provided by investing activities	47,500	841,020
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(114,194)	(354,061)
Cash and cash equivalents, beginning	1,055,755	1,632,938
Cash and cash equivalents, ending	941,561	1,278,877
Series 15
Cash flows from operating activities:
Net Income (Loss)	0	(35,236)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on Disposition of Operating Partnerships	0	(12,500)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	(43,126)
Net cash provided by (used in) operating activities	0	(90,862)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	12,500
Net cash provided by investing activities	0	12,500
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	(78,362)
Cash and cash equivalents, beginning	0	244,074
Cash and cash equivalents, ending	0	165,712
Series 16
Cash flows from operating activities:
Net Income (Loss)	(21,267)	(65,997)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on Disposition of Operating Partnerships	(47,500)	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	4,500	(2,000)
(Decrease) Increase in accounts payable affiliates	(33,040)	(115,641)
Net cash provided by (used in) operating activities	(97,307)	(183,638)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	47,500	0
Net cash provided by investing activities	47,500	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(49,807)	(183,638)
Cash and cash equivalents, beginning	191,974	320,396
Cash and cash equivalents, ending	142,167	136,758
Series 17
Cash flows from operating activities:
Net Income (Loss)	(44,966)	53,830
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on Disposition of Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	(2,500)	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	(47,466)	53,830
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(47,466)	53,830
Cash and cash equivalents, beginning	607,576	536,326
Cash and cash equivalents, ending	560,110	590,156
Series 18
Cash flows from operating activities:
Net Income (Loss)	(48,817)	755,608
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on Disposition of Operating Partnerships	0	(815,520)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	31,896	(881,521)
Net cash provided by (used in) operating activities	(16,921)	(941,433)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	815,520
Net cash provided by investing activities	0	815,520
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(16,921)	(125,913)
Cash and cash equivalents, beginning	256,205	351,136
Cash and cash equivalents, ending	239,284	225,223
Series 19
Cash flows from operating activities:
Net Income (Loss)	0	(19,978)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on Disposition of Operating Partnerships	0	(13,000)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	(32,978)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	13,000
Net cash provided by investing activities	0	13,000
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	(19,978)
Cash and cash equivalents, beginning	0	181,006
Cash and cash equivalents, ending	$ 0	$ 161,028

CONDENSED BALANCE SHEETS - USD ($)	Sep. 30, 2019	Mar. 31, 2019
ASSETS
INVESTMENTS IN OPERATING PARTNERSHIPS(Note D)	$ 0	$ 0
OTHER ASSETS
Cash and cash equivalents	941,561	1,055,755
Assets	941,561	1,055,755
LIABILITIES
Accounts payable & accrued expenses	6,500	4,500
Accounts payable affiliates (Note C)	10,779,247	10,780,391
Capital contributions payable (Note D)	18,554	18,554
Liabilities	10,804,301	10,803,445
PARTNERS' CAPITAL (DEFICIT)
Assignees Units of limited partnership interest	(10,771,022)	(10,657,123)
General Partner	908,282	909,433
Partners' capital (deficit)	(9,862,740)	(9,747,690)
Liabilities and Stockholders' Equity	941,561	1,055,755
Series 15
ASSETS
INVESTMENTS IN OPERATING PARTNERSHIPS(Note D)	0	0
OTHER ASSETS
Cash and cash equivalents	0	0
Assets	0	0
LIABILITIES
Accounts payable & accrued expenses	0	0
Accounts payable affiliates (Note C)	0	0
Capital contributions payable (Note D)	0	0
Liabilities	0	0
PARTNERS' CAPITAL (DEFICIT)
Assignees Units of limited partnership interest	(2,439,314)	(2,439,314)
General Partner	2,439,314	2,439,314
Partners' capital (deficit)	0	0
Liabilities and Stockholders' Equity	0	0
Series 16
ASSETS
INVESTMENTS IN OPERATING PARTNERSHIPS(Note D)	0	0
OTHER ASSETS
Cash and cash equivalents	142,167	191,974
Assets	142,167	191,974
LIABILITIES
Accounts payable & accrued expenses	6,500	2,000
Accounts payable affiliates (Note C)	7,781,803	7,814,843
Capital contributions payable (Note D)	0	0
Liabilities	7,788,303	7,816,843
PARTNERS' CAPITAL (DEFICIT)
Assignees Units of limited partnership interest	(7,103,067)	(7,082,013)
General Partner	(543,069)	(542,856)
Partners' capital (deficit)	(7,646,136)	(7,624,869)
Liabilities and Stockholders' Equity	142,167	191,974
Series 17
ASSETS
INVESTMENTS IN OPERATING PARTNERSHIPS(Note D)	0	0
OTHER ASSETS
Cash and cash equivalents	560,110	607,576
Assets	560,110	607,576
LIABILITIES
Accounts payable & accrued expenses	0	2,500
Accounts payable affiliates (Note C)	0	0
Capital contributions payable (Note D)	0	0
Liabilities	0	2,500
PARTNERS' CAPITAL (DEFICIT)
Assignees Units of limited partnership interest	926,717	971,233
General Partner	(366,607)	(366,157)
Partners' capital (deficit)	560,110	605,076
Liabilities and Stockholders' Equity	560,110	607,576
Series 18
ASSETS
INVESTMENTS IN OPERATING PARTNERSHIPS(Note D)	0	0
OTHER ASSETS
Cash and cash equivalents	239,284	256,205
Assets	239,284	256,205
LIABILITIES
Accounts payable & accrued expenses	0	0
Accounts payable affiliates (Note C)	2,997,444	2,965,548
Capital contributions payable (Note D)	18,554	18,554
Liabilities	3,015,998	2,984,102
PARTNERS' CAPITAL (DEFICIT)
Assignees Units of limited partnership interest	(2,438,719)	(2,390,390)
General Partner	(337,995)	(337,507)
Partners' capital (deficit)	(2,776,714)	(2,727,897)
Liabilities and Stockholders' Equity	239,284	256,205
Series 19
ASSETS
INVESTMENTS IN OPERATING PARTNERSHIPS(Note D)	0	0
OTHER ASSETS
Cash and cash equivalents	0	0
Assets	0	0
LIABILITIES
Accounts payable & accrued expenses	0	0
Accounts payable affiliates (Note C)	0	0
Capital contributions payable (Note D)	0	0
Liabilities	0	0
PARTNERS' CAPITAL (DEFICIT)
Assignees Units of limited partnership interest	283,361	283,361
General Partner	(283,361)	(283,361)
Partners' capital (deficit)	0	0
Liabilities and Stockholders' Equity	$ 0	$ 0